[{"id":"64165b3f-b55d-41f6-83d8-fad55beb1590","acronym":"","url":"https://clinicaltrials.gov/study/NCT05275868","created_at":"2022-03-11T14:53:23.220Z","updated_at":"2024-07-02T16:35:17.689Z","phase":"Phase 1","brief_title":"Study of MGY825 in Patients With Advanced Non-small Cell Lung Cancer","source_id_and_acronym":"NCT05275868","lead_sponsor":"Novartis Pharmaceuticals","biomarkers":" KEAP1 • NFE2L2","pipe":" | ","alterations":" KEAP1 mutation • NFE2L2 mutation","tags":["KEAP1 • NFE2L2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e KEAP1 mutation • NFE2L2 mutation"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e MGY825"],"overall_status":"Recruiting","enrollment":" Enrollment 140","initiation":"Initiation: 10/05/2022","start_date":" 10/05/2022","primary_txt":" Primary completion: 08/17/2026","primary_completion_date":" 08/17/2026","study_txt":" Completion: 08/17/2026","study_completion_date":" 08/17/2026","last_update_posted":"2024-02-26"}]